Antipsychotic trials in schizophrenia :  the CATIE project / 
edited by T. Scott Stroup, Jeffrey A. Lieberman. 
 - Cambridge :  Cambridge University Press,  2010. 
 - xvii, 312 p. :  ill. ;  24 cm. 
 - Cambridge medicine .
 - Cambridge medicine. .
<br/><br/>Includes bibliographical references and index. 
<br/><br/>Machine generated contents note: Introduction: Rationale for an independent, pragmatic study of antipsychotic treatments Jeffrey Lieberman; 1. Study design and protocol development process Scott Stroup, Joe McEvoy and Jeffrey Lieberman; 2. Statistical considerations Sonia Davis and Gary Koch; 3. Efficacy and effectiveness Joe McEvoy, Scott Stroup and Jeffrey Lieberman; 4. Measures of global effectiveness, cost-effectiveness Bob Rosenheck; 5. Quality of life and recovery Marvin Swartz; 6. Neurocognition Rich Keefe; 7. Vocational outcomes Sandra Resnick et al.; 8. Family outcomes Deborah Perlick et al.; 9. Neurologic side effects Stan Caroff, Del Miller and Bob Rosenheck; 10. Metabolic side effects and risk of cardiovascular disease Jonathan Meyer, Don Goff and Joe McEvoy; 11. Substance abuse Fred Reimherr and Marvin Swartz; 12. Violence Jeff Swanson and Richard van Dorn; 13. Genetics Patrick Sullivan; 14. Human subjects considerations Scott Stroup, Scott Kim and Paul Appelbaum; 15. Pharmacokinetics Bruce Pollock; 16. Implications of the CATIE project on research design and implementation Scott Stroup and Jeffrey Lieberman; 17. Conclusions-impact of the study and implications for dissemination, practice and policy formation Scott Stroup, Bob Rosenheck and Jeffrey Lieberman; Index. 
<br/><br/><label>ISBN: </label>9780521895330 (hbk.) 
<br/><br/><label>Subjects--Corporate Names: </label><br/>CATIE Project.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic drugs--Testing.<br/>Schizophrenia--Chemotherapy.
<br/><br/><label>Dewey Class. No.: </label>616.89806  / ANT 2010